These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 33581875)

  • 1. Quality of Life After Bladder Cancer: A Cross-sectional Survey of Patient-reported Outcomes.
    Catto JWF; Downing A; Mason S; Wright P; Absolom K; Bottomley S; Hounsome L; Hussain S; Varughese M; Raw C; Kelly P; Glaser AW
    Eur Urol; 2021 May; 79(5):621-632. PubMed ID: 33581875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life after a diagnosis of bladder cancer: a longitudinal survey over the first year.
    Rogers Z; Glaser A; Catto JWF; Bottomley S; Jubber I; Kotwal S; Brittain P; Gill J; Rogers MA; Dooldeniya MD; Koenig P; Cresswell J; Chahal R; Bryan N; Smith NJ; Pritchard K; Abbasi Z; Mason SJ; Absolom K; Downing A
    BJU Int; 2024 Apr; 133(4):460-473. PubMed ID: 38031657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexual Activity, Function and Dysfunction After a Diagnosis of Bladder Cancer.
    Jubber I; Rogers Z; Catto JW; Bottomley S; Glaser A; Downing A; Absolom K
    J Sex Med; 2022 Sep; 19(9):1431-1441. PubMed ID: 35871051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Europa Uomo Patient Reported Outcome Study (EUPROMS): Descriptive Statistics of a Prostate Cancer Survey from Patients for Patients.
    Venderbos LDF; Deschamps A; Dowling J; Carl EG; Remmers S; van Poppel H; Roobol MJ
    Eur Urol Focus; 2021 Sep; 7(5):987-994. PubMed ID: 33281109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related Quality of Life During the First 4 Years After Non-Muscle-invasive Bladder Cancer Diagnosis: Results of a Large Multicentre Prospective Cohort.
    Beeren I; Klerks NE; Aben KK; Oddens JR; Witjes JA; Kiemeney LA; Vrieling A
    Eur Urol Oncol; 2024 Aug; 7(4):829-837. PubMed ID: 37996278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the validity of EQ-5D-5L in people with head & neck cancer: Does a generic quality of life measure perform as well as a disease-specific measure in a patient population?
    Davies A; Waylen A; Leary S; Thomas S; Pring M; Janssen B; Beynon R; Lang S; Schimansky S; Hurley K; Ness A
    Oral Oncol; 2020 Feb; 101():104504. PubMed ID: 31835074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study.
    Downing A; Wright P; Hounsome L; Selby P; Wilding S; Watson E; Wagland R; Kind P; Donnelly DW; Butcher H; Catto JWF; Cross W; Mason M; Sharp L; Weller D; Velikova G; McCaughan E; Mottram R; Allen M; Kearney T; McSorley O; Huws DW; Brewster DH; McNair E; Gavin A; Glaser AW
    Lancet Oncol; 2019 Mar; 20(3):436-447. PubMed ID: 30713036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery of health-related quality of life in patients undergoing robot-assisted radical cystectomy with intracorporeal diversion.
    Abozaid M; Tan WS; Khetrapal P; Baker H; Duncan J; Sridhar A; Briggs T; Selim M; Abdallah MM; Elmahdy AA; Elserafy F; Kelly JD
    BJU Int; 2022 Jan; 129(1):72-79. PubMed ID: 34092021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring the Time to Deterioration for Health-Related Quality of Life in Patients With Metastatic Breast Cancer Using a Web-Based Monitoring Application: Longitudinal Cohort Study.
    Brusniak K; Feisst M; Sebesteny L; Hartkopf A; Graf J; Engler T; Schneeweiss A; Wallwiener M; Deutsch TM
    JMIR Cancer; 2021 Oct; 7(4):e25776. PubMed ID: 34636732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midterm Health-related Quality of Life After Radical Cystectomy: A Propensity Score-matched Analysis.
    Kretschmer A; Grimm T; Buchner A; Jokisch F; Ziegelmüller B; Casuscelli J; Schulz G; Stief CG; Karl A
    Eur Urol Focus; 2020 Jul; 6(4):704-710. PubMed ID: 30853603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline Health-related Quality of Life Predicts Bladder Cancer-specific Survival Following Radical Cystectomy.
    Westhofen T; Eismann L; Buchner A; Schlenker B; Giessen-Jung C; Becker A; Stief CG; Kretschmer A
    Eur Urol Focus; 2022 Nov; 8(6):1659-1665. PubMed ID: 35184991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
    Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
    J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after.
    Miret C; Orive M; Sala M; García-Gutiérrez S; Sarasqueta C; Legarreta MJ; Redondo M; Rivero A; Castells X; Quintana JM; Garin O; Ferrer M;
    Qual Life Res; 2023 Apr; 32(4):989-1003. PubMed ID: 36630024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DIFFERENTIATION OF HEALTH-RELATED QUALITY OF LIFE OUTCOMES BETWEEN FIVE DISEASE AREAS: RESULTS FROM AN INTERNATIONAL SURVEY OF PATIENTS.
    Efthymiadou O; Mossman J; Kanavos P
    Int J Technol Assess Health Care; 2018 Jan; 34(5):498-506. PubMed ID: 30251618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of Life of Cancer Patients during Chemotherapy in Indonesia: A Comparison of EORTC QLQ-C30 and EQ-5D-5L, Based on Patients' Characteristics.
    Perwitasari DA; Purba FD; Candradewi SF; Dania H; Muhammad Irham L; Noor Faridah I; Septiantoro BP
    Int J Clin Pract; 2023; 2023():9357299. PubMed ID: 36908296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-Related Quality of Life and Health Utilities in Metastatic Castrate-Resistant Prostate Cancer: A Survey Capturing Experiences from a Diverse Sample of UK Patients.
    Lloyd AJ; Kerr C; Penton J; Knerer G
    Value Health; 2015 Dec; 18(8):1152-7. PubMed ID: 26686802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "The validity of the EQ-5D-5L in measuring quality of life benefits of breast reconstruction".
    Kouwenberg CAE; Kranenburg LW; Visser MS; Busschbach JJ; Mureau MAM
    J Plast Reconstr Aesthet Surg; 2019 Jan; 72(1):52-61. PubMed ID: 30270015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related Quality of Life with Adjuvant Nivolumab After Radical Resection for High-risk Muscle-invasive Urothelial Carcinoma: Results from the Phase 3 CheckMate 274 Trial.
    Witjes JA; Galsky MD; Gschwend JE; Broughton E; Braverman J; Nasroulah F; Maira-Arce M; Ye X; Shi L; Guo S; Hamilton M; Bajorin DF
    Eur Urol Oncol; 2022 Oct; 5(5):553-563. PubMed ID: 35288066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma.
    Proskorovsky I; Lewis P; Williams CD; Jordan K; Kyriakou C; Ishak J; Davies FE
    Health Qual Life Outcomes; 2014 Mar; 12():35. PubMed ID: 24618388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health related quality of life in patients with bladder cancer: a cross-sectional survey and validation study of the Hungarian version of the Bladder Cancer Index.
    Hevér NV; Péntek M; Balló A; Gulácsi L; Baji P; Brodszky V; Damásdi M; Bognár Z; Tóth G; Buzogány I; Szántó Á
    Pathol Oncol Res; 2015 Jul; 21(3):619-27. PubMed ID: 25434791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.